• Organized by the Cross Company Abuse Liability Consortium (CCALC)

  • Facilitated with the aid of the College on Problems of Drug Dependence (CPDD)

  • With presentations by the FDA representatives 

Abuse Deterrent Formulation Science Meeting 

Discussion of the FDA Draft Guidance for Industry: Abuse Deterrent Opioids – Evaluation and Labeling


Meeting registration is closed


Contact Us